Secondary Adrenocortical Insufficiency as a Result of Chronic Fentanyl Treatment: A Case Report
Journal Title: Clinical Medical Reviews and Case Reports - Year 2017, Vol 4, Issue 5
Abstract
Hypothalamus-Pituitary-Adrenal (HPA) may be disturbed by drugs, including opioids. In fact, opioids are a well-recognized cause of hypogonadotropic hypogonadism due to its effects in the hypothalamic-pituitary-gonads axis. Nevertheless, these results are not observed in all the studies and there are numerous contradictions in the literature.
Authors and Affiliations
Keywords
Related Articles
- EP ID EP272279
- DOI 10.23937/2378-3656/1410167
- Views 122
- Downloads 0
Advances in the Management of Skin Wounds with Synthetic Dressings
Treating wounds under normal wound healing processes often require little or no intervention, consisting primarily of debridement, as during the inflammatory stage the cells clear the wound to healing. However wound care...
Socket Reconstruction after Firework Explosion Injury
We report a challenging case of orbital socket reconstruction. A 49- year-old man presented two weeks after fireworks exploded in his face. He had multiple orbital bone fractures on the right and the globe was enucleated...
Successful Resolution of Uremic Tumoral Calcinosis with Conventional Hemodialysis Using a Low-Calcium Containing Dialysate
A 40-year-old Caucasian man with end-stage renal disease (ERSD) due unknown cause had been on continuous ambulatory peritoneal dialysis (CAPD) since 2009 with 3.5 meq/l calcium dialysate.
Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens with Other PI's/NNRTI's in HIV + Children and Adolescents with Elevated Lipid Levels
A frequent side-effect of antiretroviral therapy is elevation of plasma lipids and cholesterol. Atazanavir has been shown in adults to have a smaller elevation in plasma lipids in relation to other protease inhibitors. T...
Blue Fingernails during Treatment with Cyclophosphamide for Minimal Change Disease: A Very Rare Side Effect
We present the case of a 52-year-old lady affected with cortico dependent minimal change disease who developed a blue pigmentation of her fingernails during a 3-months treatment with cyclophosphamide for cortico dependen...